Inventor · disambiguated record
Philip B. Graham
Also filed as: GRAHAM PHILIP · GRAHAM PHILIP B
10 granted patents·10 pending applications·55 citations·filing 2006–2024
90Inventor score
Files withCONCERT PHARMACEUTICALS INC12GRAHAM PHILIP B2SUN PHARMACEUTICAL IND INC2CONCERT PHARMACEUTICAL INC1MCMURRY THOMAS J1
Top patents by PatentIndex Score
20 records- 0194US9655895B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·7 cites·20 claims
- 0293US9340512B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·5 cites·15 claims
- 0392US8916582B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Dec 23, 2014·7 cites·18 claims
- 0491US10022370B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2017·Granted Jul 17, 2018·3 cites·21 claims
- 0589US8710072B2Morphinan compoundsGRAHAM PHILIP B·Filed 2009·Granted Apr 29, 2014·15 cites·15 claims
- 0687US9266837B2Morphinan compoundsCONCERT PHARMACEUTICAL INC·Filed 2014·Granted Feb 23, 2016·5 cites·10 claims
- 0786US10561659B2Treatment of hair loss disorders with deuterated JAK inhibitorsCONCERT PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·9 cites·21 claims
- 0884US10406155B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·2 cites·22 claims
- 0983US12076323B2Treatment of hair loss disorders with deuterated JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2019·Granted Sep 3, 2024·2 cites·29 claims
- 1078US10813926B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·22 claims
- 1175US2024423986A1Treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1264US2019336494A1Deuterated morphinan compounds for treating agitationCONCERT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1361US2012029007A1Morphinan compoundsGRAHAM PHILIP B·Filed 2011·Application pending·0 cites
- 1457US2024202724A1Apparatus and methods for identification using third-party verifiersThe Beneficiary Liquidity Plan·Filed 2022·Application pending·0 cites
- 1554US2018243291A1Deuterated morphinan compounds for treating agitationCONCERT PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1651US2007111947A1Fibrin targeted therapeuticsMCMURRY THOMAS J·Filed 2006·Application pending·0 cites
- 1740US2015328220A1Methods of treating chronic kidney disease characterized by macroalbuminuriaCONCERT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1840US2020216396A1Deuterated forms of isoquinolinone and methods of use thereofSOJOURNIX INC·Filed 2020·Application pending·0 cites
- 1938US2018243290A1Morphinan compounds for treating agitationCONCERT PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2037US2018208566A1Deuterated MeclizineCONCERT PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →